Immunovant (IMVT) Debt Ratio (2019 - 2023)

Immunovant has reported Debt Ratio for 4 years, with the latest figure at 0.0 in Q1 2023.

• For the quarter ending Q1 2023, Debt Ratio rose 160.02% year-over-year to 0.0; the trailing twelve-month figure through Mar 2023 stood at 0.0 (up 160.02% YoY), and the FY2023 full-year result was 0.0, up 160.02% from the prior year.
• Debt Ratio for Q1 2023 stood at 0.0, up from 0.0 in the prior quarter.
• The five-year high for Debt Ratio was 0.04 in Q2 2019, with the low at 0.0 in Q3 2020.
• Historically, Debt Ratio has averaged 0.01 across 4 years, with a median of 0.0 in 2019.
• The largest YoY upside for Debt Ratio was 595.27% in 2020 against a maximum downside of 98.61% in 2020.
• Immunovant's Debt Ratio stood at 0.02 in 2019, then plunged by 98.81% to 0.0 in 2020, then climbed by 12.35% to 0.0 in 2022, then jumped by 160.02% to 0.0 in 2023.
• The last three Debt Ratio figures came in at 0.0 (Q1 2023), 0.0 (Q1 2022), and 0.0 (Q3 2020), per Business Quant data.